Skip to main content
PFSA
NASDAQ Industrial Applications And Services

Profusa Secures Highly Dilutive Equity Line of Credit Draw with 'True-Up' Mechanism Amidst Financial Distress

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.269
Mkt Cap
$1.25M
52W Low
$0.263
52W High
$957.003
52W Position info
2.6% above low
Off High info
100% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

PFSA is trading near its 52-week low of $0.263 (2.6% above the low) on light trading volume (0.1× avg).

Summary

Profusa has initiated a highly dilutive draw on its Equity Line of Credit with a 'True-Up Mechanism' that will issue more shares if the stock price drops, exacerbating dilution for existing shareholders.


Key Events · Financing and Capital Events · PFSA

  • Highly Dilutive Equity Line of Credit (ELOC) Draw

    Profusa submitted an Advance Notice to Ascent Partners Fund LLC to draw on its ELOC, capped at $200,000 per notice, to secure immediate capital.

  • Unfavorable ELOC Terms with 'True-Up' Mechanism

    The ELOC draw is priced at 97% of the lowest 10-day VWAP, with payment upon delivery. A critical 'True-Up Mechanism' requires Profusa to issue additional shares if the stock price declines further, leading to potentially unlimited dilution.

  • Massive Share Resale Registered by Selling Stockholders

    The prospectus supplement updates the registration for the resale of up to 179.3 million shares by selling stockholders, representing thousands of percent potential dilution relative to current outstanding shares. The company will not receive proceeds from these specific resales.

  • Ongoing Financial Distress and Delisting Concerns

    This financing occurs while the company faces severe financial challenges, including a going concern warning, increased losses, and Nasdaq delisting threats, with its stock trading near 52-week lows.


Analysis · PFSA · Industrial Applications And Services

Profusa, a micro-cap company already facing severe financial distress and Nasdaq delisting threats, has initiated a draw on its Equity Line of Credit (ELOC) under extremely unfavorable terms. The inclusion of a 'True-Up Mechanism' means the company will issue additional shares if the stock price continues to fall, leading to potentially unlimited dilution for existing shareholders. This move, coupled with the ongoing registration for resale of 179.3 million shares (representing thousands of percent dilution), highlights the company's desperate need for capital and the significant risk to current investors.

At the time of this filing, PFSA was trading at $0.27 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3M. The 52-week trading range was $0.26 to $957.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Jul 07, 2026, 8:52 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.088
Real-time Price: $1.79 info
Change: Reverse Stock Split info
Market Cap: $948.7K info
PFSA
Jul 07, 2026, 8:43 AM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.088
Real-time Price: $1.79 info
Change: Reverse Stock Split info
Market Cap: $948.7K info
PFSA
Jul 07, 2026, 8:39 AM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.088
Real-time Price: $1.79 info
Change: Reverse Stock Split info
Market Cap: $948.7K info
PFSA
Jul 07, 2026, 8:37 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.088
Real-time Price: $1.79 info
Change: Reverse Stock Split info
Market Cap: $948.7K info
PFSA
Jul 06, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.1092
Real-time Price: $1.79 info
Change: Reverse Stock Split info
Market Cap: $948.7K info